Pharmaceuticals save lives.
But the systems that support their production, use, and disposal are under growing pressure.
By 2028, the global pharmaceutical market will reach USD 2.3 trillion and 3.78 trillion doses/year (up from USD 1.21 trillion and 2.96 trillion doses in 2018) — yet pollution impacts remain dangerously under-addressed (IQVIA 2024).
A growing issue
Pharmaceuticals enter the environment at every stage—production, use, and disposal. The consequences are already clear: rising antimicrobial resistance, polluted ecosystems, and declining biodiversity. These impacts are creating mounting financial, regulatory, operational, and strategic risks across the system—from global pharmaceutical corporations and national health services to regional pharmacies and local waste managers.
Transformational solutions for a sustainable future
We take a systems perspective—looking across the entire lifecycle, convening diverse stakeholders, and designing solutions that protect people, profit, and planet.
SYSTEMS THINKING
Mapping the bigger picture across supply, use, and disposal
COLLABORATION
Bringing healthcare, industry, policy and research together
ACTION PATHWAYS
Turning evidence into practical solutions and policy impact
Trusted by Leading Funders
Latest Outputs
EXAMPLE:
3 linked cards —
Report – Mapping the UK healthcare pharmaceutical system
Identifying 37 leverage points for sustainable action.
Blog- What systems thinking means for pharma
How complexity science helps us find real solutions.
Publication – Call to Action (2022)
Evidence base for urgent collective action.
Watch: Pharmapollution in 2 minutes
(need a better heading…)